Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765682 · ClinicalTrials.gov registry record · NA
Mepivacaine Vs. Bupivacaine Spinal for TKA
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT05765682 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 160 participants.
The verdict
NCT05765682, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study will enroll patients 18-75 years of age who are undergoing elective primary total knee replacement. The patients will be randomized to receive one of two spinal blocks: 1) mepivacaine or 2) bupivacaine. The primary goal is to determine which group arrives at recovery of motor function first. Ultimately, this study will explore if mepivacaine leads to earlier return of motor function and ultimately earlier movement and discharge times following total knee replacement.
Interventions
- OTHER Mepivacaine Spinal
- OTHER Bupivacaine Spinal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2024-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05765682
The ClinicalTrials.gov registry entry for NCT05765682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mepivacaine Spinal is the first listed.
NCT05765682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05765682 about?
NCT05765682 is a clinical study titled "Mepivacaine Vs. Bupivacaine Spinal for TKA". This study will enroll patients 18-75 years of age who are undergoing elective primary total knee replacement. The patients will be randomized to receive one of two spinal blocks: 1) mepivacaine or 2) bupivacaine. The primary goal is to determine which group arrives at recovery of motor function fir...
What is the current status of trial NCT05765682?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2023-03-13. Estimated completion is 2024-08-25.
What interventions are being tested in trial NCT05765682?
The interventions under investigation include: Mepivacaine Spinal (OTHER), Bupivacaine Spinal (OTHER).
Who is sponsoring clinical trial NCT05765682?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.